[HTML][HTML] Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysis

MJY Kang, J Grewal, D Eratne, C Malpas… - Brain, Behavior, and …, 2024 - Elsevier
Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are biomarkers of
neuronal injury measurable in cerebrospinal fluid (CSF) and blood. Despite their potential …

Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders

D Eratne, M Kang, C Malpas… - Australian & New …, 2024 - journals.sagepub.com
Objective: Blood biomarkers of neuronal injury such as neurofilament light (NfL) show
promise to improve diagnosis of neurodegenerative disorders and distinguish …

Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders

MJY Kang, D Eratne, H Dobson, CB Malpas… - Acta …, 2024 - cambridge.org
Objective: People with neuropsychiatric symptoms often experience delay in accurate
diagnosis. Although cerebrospinal fluid neurofilament light (CSF NfL) shows promise in …

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

A Vrillon, NJ Ashton, TK Karikari, K Götze, E Cognat… - Journal of …, 2024 - Springer
Plasma neurofilament light chain (NfL) is a promising biomarker of axonal damage for the
diagnosis of neurodegenerative diseases. Phosphorylated neurofilament heavy chain …

Cortical thickness modeling and variability in Alzheimer's disease and frontotemporal dementia

A Pérez-Millan, S Borrego-Écija, N Falgàs… - Journal of …, 2024 - Springer
Background and objective Alzheimer's disease (AD) and frontotemporal dementia (FTD)
show different patterns of cortical thickness (CTh) loss compared with healthy controls (HC) …

Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders

H Dobson, S Al Maawali, C Malpas, AF Santillo… - …, 2024 - Wiley Online Library
Objective Research suggests that recurrent seizures may lead to neuronal injury.
Neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAP) levels …

The myth of brain damage: no change of neurofilament light chain during transient cognitive side-effects of ECT

M Besse, M Belz, C Bartels, B Herzig, J Wiltfang… - European archives of …, 2024 - Springer
Electroconvulsive therapy (ECT) is an effective, safe, and mostly well-tolerated treatment for
patients with severe or difficult to treat depression or psychotic disorders. However, a …

Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting

D Eratne, MJY Kang, C Lewis, C Dang… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION People with neurodegenerative disorders (ND) frequently face diagnostic
delay and misdiagnosis. We investigated blood and cerebrospinal fluid (CSF) neurofilament …

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort

D Eratne, QX Li, C Lewis, C Dang, MJY Kang… - Journal of …, 2025 - Springer
Objective We investigated diagnostic utility of phosphorylated tau 217 and 181 (ptau217,
ptau181), glial fibrillary acidic protein (GFAP), amyloid beta 42 and 40 (Aβ42, Aβ40), and …

Social cognition differentiates phenocopy syndrome of behavioural variant frontotemporal dementia from behavioural variant frontotemporal dementia

MPE van Engelen, P Louwers, JLP Fieldhouse… - …, 2024 - Wiley Online Library
Background Patients displaying clinical features of behavioural variant of frontotemporal
dementia (bvFTD) but lacking both neuroimaging abnormalities and clinical progression are …